Trial intelligence / Profile preview

Efficacy of Fluzone High-Dose vs Standard Dose in Elderly

NCT01427309Phase 4Completed

Sponsor
Sanofi
Start
Sep 2011
Primary completion
May 2013
Modality
Vaccines & Immunotherapeutics
Countries
3
01

Overview

A Phase 4 trial of trivalent inactivated influenza vaccine high-dose in influenza, sponsored by Sanofi. Started Sep 2011; status: completed.

02

Drugs

trivalent inactivated influenza vaccine high-dose
03

Conditions

influenza

Beyond the preview

Go deeper on NCT01427309.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01427309.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call